Second Sight Reports Fourth Quarter and Full Year 2019 Financial Results
LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today reported financial results for the three months and full year ended December 31, 2019. Recent Financial and Corporate Highlights: Received CE Mark Certification and U.S. Food and Drug Administration (“FDA”) conditiona